Catalyst Pharmaceuticals (CPRX) Earnings Date, Estimates & Call Transcripts $24.63 +0.26 (+1.07%) Closing price 05/19/2025 04:00 PM EasternExtended Trading$24.58 -0.05 (-0.22%) As of 09:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Catalyst Pharmaceuticals Earnings Summary Catalyst Pharmaceuticals posted Q2 2024 earnings on August 7, 2024, reporting an EPS of $0.52, which beat analysts' consensus estimates of $0.39 by $0.13. Quarterly revenue was reported to be $122.71 million, above analyst estimates of $111.76 million. With a trailing EPS of $1.57 and a P/E Ratio of 20.87, Catalyst Pharmaceuticals' earnings are expected to grow 12.11% next year, from $1.90 to $2.13 per share. Upcoming Q3 Earnings DateAug. 6After Market ClosesEstimatedConsensus EPS (Aug. 7) $0.39 Actual EPS (Aug. 7) $0.52 Beat By $0.13 Actual Revenue (Aug. 7) $122.71MQ2 2024 Earnings ResourcesQ2 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)CPRX Upcoming EarningsCatalyst Pharmaceuticals' next earnings date is estimated for Wednesday, August 6, 2025, based on past reporting schedules. Powered by Get Catalyst Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Catalyst Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCPRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CPRX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Catalyst Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20251$0.49$0.49$0.49Q2 20251$0.51$0.51$0.51Q3 20251$0.49$0.49$0.49Q4 20251$0.53$0.53$0.53 FY 2025 4 $2.02 $2.02 $2.02 Q1 20261$0.57$0.57$0.57Q2 20261$0.55$0.55$0.55Q3 20261$0.57$0.57$0.57Q4 20261$0.57$0.57$0.57 Catalyst Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/6/2025(Estimated)--------8/7/2024Q2 2024$0.39$0.52+$0.13$0.71$111.76M$122.71M5/8/2024Q1 2024$0.31$0.31-$0.43$97.24M$98.51M2/28/2024Q4 2023$0.45$0.49+$0.04$0.67$105.78M$110.57M11/8/2023Q3 2023-$0.26-$0.26--$0.23$100.17M$102.69M8/9/2023Q2 2023$0.25$0.33+$0.08$0.33$92.77M$99.58M Catalyst Pharmaceuticals Earnings - Frequently Asked Questions When is Catalyst Pharmaceuticals's earnings date? Catalyst Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based off last year's report dates. Learn more on CPRX's earnings history. What guidance has Catalyst Pharmaceuticals issued on next quarter's earnings? Catalyst Pharmaceuticals issued an update on its FY 2025 earnings guidance on Wednesday, May, 7th. The company issued revenue guidance of $545.0 million-$565.0 million, compared to the consensus revenue estimate of $557.2 million. Did Catalyst Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Catalyst Pharmaceuticals (NASDAQ:CPRX) reported $0.52 earnings per share (EPS) to beat the analysts' consensus estimate of $0.39 by $0.13. Learn more on analysts' earnings estimate vs. CPRX's actual earnings. How can I listen to Catalyst Pharmaceuticals's earnings conference call? The conference call for Catalyst Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Catalyst Pharmaceuticals's conference call transcript? The conference call transcript for Catalyst Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Catalyst Pharmaceuticals generate each year? Catalyst Pharmaceuticals (NASDAQ:CPRX) has a recorded annual revenue of $534.65 million. How much profit does Catalyst Pharmaceuticals generate each year? Catalyst Pharmaceuticals (NASDAQ:CPRX) has a recorded net income of $71.41 million. CPRX has generated $1.57 earnings per share over the last four quarters. What is Catalyst Pharmaceuticals's price-to-earnings ratio? Catalyst Pharmaceuticals (NASDAQ:CPRX) has a trailing price-to-earnings ratio of 20.87 and a forward price-to-earnings ratio of 12.96. The price/earnings-to-growth ratio is 3.31. What is Catalyst Pharmaceuticals's EPS forecast for next year? Catalyst Pharmaceuticals's earnings are expected to grow from $1.90 per share to $2.13 per share in the next year, which is a 12.11% increase. More Earnings Resources from MarketBeat Related Companies RDY Earnings VTRS Earnings MRNA Earnings QGEN Earnings ASND Earnings ROIV Earnings RVMD Earnings BBIO Earnings BPMC Earnings ELAN Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NASDAQ:CPRX) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredDollar Collapse Warning: Protect Your Wealth NOWGlobal central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredTrump’s treachery A shocking bill has been put before the House of Representatives… Representative Brandon Gill wants Preside...Porter & Company | SponsoredMiners are priced like gold is $1,000 as gold hits $3,500…A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalyst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catalyst Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CPRX Stock Free CPRX Stock Alerts